Group 1 - The core viewpoint of the news is that Minsheng Health has shown a mixed performance in terms of financing and stockholder metrics, with a notable increase in revenue and net profit year-on-year [1][2]. Group 2 - On January 9, Minsheng Health's stock price increased by 0.87%, with a trading volume of 132 million yuan. The financing buy-in amount was 14.12 million yuan, while the financing repayment was 15.40 million yuan, resulting in a net financing buy of -1.28 million yuan [1]. - As of January 9, the total balance of margin trading for Minsheng Health was 91.35 million yuan, with a financing balance of 91.08 million yuan, accounting for 5.08% of the circulating market value, which is below the 40th percentile level over the past year [1]. - The company has a high short-selling balance, with a short-selling volume of 16,400 shares and a short-selling balance of 266,200 yuan, exceeding the 90th percentile level over the past year [1]. - As of September 30, the number of shareholders for Minsheng Health was 19,700, a decrease of 8.51% from the previous period, while the average circulating shares per person increased by 7.98% to 5,547 shares [2]. - For the period from January to September 2025, Minsheng Health achieved an operating income of 623 million yuan, representing a year-on-year growth of 19.78%, and a net profit attributable to the parent company of 114 million yuan, up 32.77% year-on-year [2]. - Since its A-share listing, Minsheng Health has distributed a total of 71.20 million yuan in dividends [3]. - As of September 30, 2025, Hong Kong Central Clearing Limited was the fifth-largest circulating shareholder, holding 1.016 million shares, a decrease of 695,500 shares from the previous period [3].
民生健康1月9日获融资买入1412.02万元，融资余额9107.95万元